Azelis announced that it has successfully completed the acquisition of Quimdis. Quimdis is a leading French distributor of ingredients for nutraceuticals, flavors & fragrances, animal nutrition, personal care, pharma and food.

 

This transaction enhances Azelis’ lateral value chain by diversifying and expanding its presence in France and EMEA

 

The acquisition of Quimdis provides Azelis in EMEA with an important foothold in the growing non-cyclical markets of flavors and fragrances, synergistic opportunities in animal nutrition, and expands its offering in nutraceuticals

 

Quimdis was founded in 1988 by Jean-François Quarré, Michel Manalt and Claire Couratier, originally focusing on essential oils and active ingredients. It now specializes in ingredients distribution and formulation development, with solid positions in the French market and with sales into more than 45 countries. Quimdis is headquartered in Paris and has sales close to  €100m. Quimdis’ 78 employees serve over 1,000 customers and c.400 suppliers.

 

This acquisition strengthens Azelis’ offering to fast-growing and attractive markets, whilst also enhancing the position of Azelis France in the life sciences sector. Azelis is now well positioned to develop, structure and implement a global strategy for flavor & fragrance market with the aim of becoming a market leader.

 

The signing of the deal was announced on July 20th, 2021 and the transaction is consistent with Azelis’ strategy of complementing organic growth with strategic acquisitions 

 

As Benoit Fritz, Managing Director of Azelis France said in August, “Azelis will leverage Quimdis’ expertise to complement our lateral value chain with reliable, natural and value-added products like essential oils and active ingredients. We will further benefit from their strong presence across EMEA, expertise and product portfolio in attractive target market segments and geographies.”